Sign inJoin waitlistJoin the waitlist

LN

Luke Nordquist

Physician · Urology Cancer Center PC

Credentials: · · ·

History

Urology Cancer Center PC
Present

University of South Florida
2001–2003
Internal Medicine
1998–2001
Creighton University School of Medicine
1994–1998

Research

Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
New England Journal of Medicine · 2021 · 2,264 citations
American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer
Journal of Clinical Oncology · 2009 · 619 citations
2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer
Journal of Clinical Oncology · 2011 · 237 citations

NS
Neal Shore
13 papers
Oliver Sartor
9 papers
Scott Tagawa
9 papers
MM
Michael Morris
6 papers
Ronald Tutrone
6 papers
CH
Celestia Higano
5 papers
CP
Christopher Pieczonka
5 papers
Andrew Armstrong
4 papers
Cora Sternberg
4 papers
Daniel Petrylak
4 papers
HS
Howard Scher
4 papers
NV
Nicholas Vogelzang
4 papers

Clinical trials

A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer
Study director · Withdrawn · Phase 2
GU Research Network, LLC
2016–2018
Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC)
Site PI · Recruiting · Phase 2
Convergent Therapeutics
2024–2027
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Site PI · Recruiting · Phase 3
Clarity Pharmaceuticals Ltd
2023–2026
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Site PI · Recruiting · Phase 4
Novartis Pharmaceuticals
2023–2033